# Conquest Research

> Conquest Research is a privately held clinical-trial site network headquartered in Winter Park, Florida. Founded in 2018 by Mark Daley, it recruits and supports study participants while running trials for pharmaceutical companies, biotechs and contract research organizations across therapeutic areas including neurology, pain, orthopedics, rheumatology, metabolic disease and sleep. After a 2023 majority investment from Reynolda Equity Partners, Conquest expanded from Central Florida into Virginia and Georgia through new sites and the acquisitions of Sana Research and NeuroTrials Research.

- **Founded:** 2018
- **Headquarters:** Winter Park, United States
- **Founders:** Mark Daley (Founder and CEO)
- **Team size:** Approximately 85 employees; LinkedIn range 51-200
- **Products:** Clinical trial site operations, Patient recruitment and engagement, Pharmaceutical and CRO site services, Physician-practice research partnerships, Multi-state specialty site network
- **Notable:** Expanded from a Central Florida operator into a six-location network spanning Florida, Virginia and Georgia., Secured a majority investment from Reynolda Equity Partners in 2023., Acquired Sana Research in 2025, adding Arlington and Tyson's Corner coverage and expertise in neurologic, cardiovascular and metabolic disease.

## Products & services

- **Clinical trial site operations** — Runs sponsor protocols through local investigators, coordinators, patient visits, safety procedures, regulatory documentation and data collection.
- **Patient recruitment and engagement** — Finds eligible participants through physician referrals, multimedia outreach, community events and direct study registration.
- **Pharmaceutical and CRO site services** — Provides multi-therapeutic research-site capacity to pharmaceutical companies, biotechs and contract research organizations.
- **Physician-practice research partnerships** — Helps medical practices offer clinical trials and investigational treatment options to their patient populations.
- **Multi-state specialty site network** — Operates and integrates research locations across Florida, Virginia and Georgia, including acquired specialist sites.

## Achievements

- Expanded from a Central Florida operator into a six-location network spanning Florida, Virginia and Georgia.
- Secured a majority investment from Reynolda Equity Partners in 2023.
- Acquired Sana Research in 2025, adding Arlington and Tyson's Corner coverage and expertise in neurologic, cardiovascular and metabolic disease.
- Acquired NeuroTrials Research in 2025, adding Atlanta and specialist experience in neurology and sleep disorders.
- The Winter Park site is publicly indexed with more than 100 historical trial records across conditions including Alzheimer's disease and osteoarthritis.
- Publicly reported top enrollment rankings in a competitive obesity and Type 2 diabetes study at Winter Park and Tyson's Corner.
- Publicly reported the first U.S. patient screened and enrolled in an osteoarthritis-of-the-knee study at its Winter Park site.

## Latest updates

- **2026-07** — Company representatives attended the Alzheimer's Association International Conference in London and promoted sponsor and physician outreach.
- **2026-07** — The company reported the first U.S. patient screened and enrolled in an osteoarthritis-of-the-knee study at Winter Park.
- **2026-06** — Conquest and the Global Alzheimer's Platform Foundation conducted community memory screenings and brain-health outreach.
- **2025-12** — Conquest acquired Atlanta-based NeuroTrials Research, its second announced add-on acquisition.
- **2025-04** — Conquest acquired Sana Research, expanding into Arlington and Tyson's Corner in Northern Virginia.

## Links

- Website: https://conquestresearch.com
- LinkedIn: https://www.linkedin.com/company/conquest-research
- Instagram: https://www.instagram.com/conquest_research/
- Facebook: https://www.facebook.com/conquestresearch/

---

Profile page: https://yespress.io/conquest-research
Published by YesPress — https://yespress.io
Last updated: 2026-08-21